NCT01000233View on ClinicalTrials.gov

Value of Oral Phytate (InsP6) in the Prevention of Progression of the Cardiovascular Calcifications

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

March 31, 2012

Study Completion Date

October 31, 2012

Conditions
Heart Valve DiseaseAortic Stenosis
Interventions
DIETARY_SUPPLEMENT

Phytine (phytate)

300 mg tid \* 24 months

DIETARY_SUPPLEMENT

Placebo

Phytine (Phytate)

Trial Locations (1)

07014

RECRUITING

Hospital Universitario Son Dureta, Palma

Sponsors

Collaborators (1)

Laboratorios BIOMED SA
All Listed Sponsors
collaborator

Laboratorios BIOMED SA

UNKNOWN

lead

Hospital Universitari Son Dureta

OTHER

NCT01000233 - Value of Oral Phytate (InsP6) in the Prevention of Progression of the Cardiovascular Calcifications | Biotech Hunter | Biotech Hunter